AMPLY Discovery Secures £900,000 for AI Drug Development
In a bold move that highlights the transformative potential of artificial intelligence in healthcare, AMPLY Discovery Limited has successfully raised £900,000 through a strategic combination of equity and grant funding. This Belfast-based biotech company, an innovative spin-out from Queen’s University Belfast, is set to revolutionize drug discovery with its unique AI-driven platform designed to address one of the critical challenges in global health: antimicrobial resistance (AMR).
Founded in 2021, AMPLY Discovery leverages more than eight years of scientific research in computational biology to pioneer the development of novel anti-infective products.
The company's flagship program targets bovine mastitis, a significant health issue in livestock, and has garnered grant support from Innovate UK as part of its ICURE Aid for Start-Ups initiative. This funding milestone not only underscores the team’s innovative approach but also positions AMPLY Discovery as a leader in the fight against infections caused by bacteria, viruses, and fungi.
The funding landscape for startups like AMPLY Discovery is increasingly robust, supported by stakeholders such as Co-Fund NI, managed by Clarendon Fund Managers, and organizations like QUBIS Innovation Fund and the Halo Business Angel Network. These investors are not just providing capital; they are endorsing a vision for a healthier future. As CEO and Co-Founder Dr. Ben Thomas remarked, “The support from our investors and Queen’s University Belfast is crucial for advancing our commercial development.” As AMPLY Discovery progresses, it stands poised to attract further investment and potentially transform the landscape of infectious disease treatment.
Key Terms Explained
- Equity and grant funding
- Equity funding is a method of raising capital where companies sell shares of their business to investors. Grant funding is typically non-repayable funds given by one party (often a government body, corporation, or foundation) to a recipient, usually for a specific project or cause.
- AI-driven platform
- An artificial intelligence (AI) driven platform is a software model, application or tool that uses AI technologies such as machine learning to perform, optimise, or automate tasks usually done by humans, making the system more efficient and precise.
- Investment
- Investment refers to the act of allocating capital or resources with the expectation of receiving a profit or material result. In the context of startups, investors typically provide funding in exchange for an ownership stake in the company.
Frequently Asked Questions
- What is the amount of funding that AMPLY Discovery Limited has raised?-AMPLY Discovery Limited has successfully raised £900,000 through a strategic combination of equity and grant funding.
- In what area is the Belfast-based biotech company, AMPLY Discovery Limited, using artificial intelligence?+
- What is the goal of AMPLY Discovery's flagship program?+
- Who are some of the investors supporting startups like AMPLY Discovery?+
- What potential transformation could further investment in AMPLY Discovery bring about?+
They've invested in AMPLY Discovery
Get to know these Healthtech investors
| Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|
 Co-Fund NI | 4 investments investments | more info | |||
 Clarendon Fund Managers | 12 investments investments | 7 contacts contacts | |||
 QUBIS Innovation Fund | 3 investments investments | more info | |||
 Halo Business Angel Network | 2 investments investments | more info | |||
 Innovate UK Investor Partnership | 53 investments investments | more info | |||
 Queen's University Belfast | 1 investment investment | more info |
Click here for a full list of 7,589+ startup investors in the UK